USPH Quote, Financials, Valuation and Earnings

Concentra Group Holdings Parent, Inc. has a net margin of 6.45% compared to U.S. Physical Therapy, Inc.'s net margin of 6.71%. U.S. Physical Therapy, Inc.'s return on equity of 8.4% beat Concentra Group Holdings Parent, Inc.'s return on equity of 47.29%.

U.S. Physical Therapy, Inc. has a consensus price target of $105.33, signalling upside risk potential of 26.53%. On the other hand Concentra Group Holdings Parent, Inc. has an analysts' consensus of $29.00 which suggests that it could grow by 23.09%. Given that U.S. Physical Therapy, Inc. has higher upside potential than Concentra Group Holdings Parent, Inc., analysts believe U.S. Physical Therapy, Inc. is more attractive than Concentra Group Holdings Parent, Inc..

U.S. Physical Therapy, Inc. has a beta of 1.301, which suggesting that the stock is 30.094% more volatile than S&P 500. In comparison Concentra Group Holdings Parent, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

U.S. Physical Therapy, Inc. has a quarterly dividend of $0.45 per share corresponding to a yield of 2.16%. Concentra Group Holdings Parent, Inc. offers a yield of 1.06% to investors and pays a quarterly dividend of $0.06 per share. U.S. Physical Therapy, Inc. pays 126.62% of its earnings as a dividend. Concentra Group Holdings Parent, Inc. pays out 19.54% of its earnings as a dividend. Concentra Group Holdings Parent, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but U.S. Physical Therapy, Inc.'s is not.

U.S. Physical Therapy, Inc. quarterly revenues are $202.7M, which are smaller than Concentra Group Holdings Parent, Inc. quarterly revenues of $539.1M. U.S. Physical Therapy, Inc.'s net income of $13.1M is lower than Concentra Group Holdings Parent, Inc.'s net income of $36.2M. Notably, U.S. Physical Therapy, Inc.'s price-to-earnings ratio is 58.82x while Concentra Group Holdings Parent, Inc.'s PE ratio is 18.31x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for U.S. Physical Therapy, Inc. is 1.62x versus 1.39x for Concentra Group Holdings Parent, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Encompass Health Corp. has a net margin of 6.45% compared to U.S. Physical Therapy, Inc.'s net margin of 13.07%. U.S. Physical Therapy, Inc.'s return on equity of 8.4% beat Encompass Health Corp.'s return on equity of 24.73%.

U.S. Physical Therapy, Inc. has a consensus price target of $105.33, signalling upside risk potential of 26.53%. On the other hand Encompass Health Corp. has an analysts' consensus of $142.73 which suggests that it could grow by 31%. Given that Encompass Health Corp. has higher upside potential than U.S. Physical Therapy, Inc., analysts believe Encompass Health Corp. is more attractive than U.S. Physical Therapy, Inc..

U.S. Physical Therapy, Inc. has a beta of 1.301, which suggesting that the stock is 30.094% more volatile than S&P 500. In comparison Encompass Health Corp. has a beta of 0.727, suggesting its less volatile than the S&P 500 by 27.328%.

U.S. Physical Therapy, Inc. has a quarterly dividend of $0.45 per share corresponding to a yield of 2.16%. Encompass Health Corp. offers a yield of 0.66% to investors and pays a quarterly dividend of $0.19 per share. U.S. Physical Therapy, Inc. pays 126.62% of its earnings as a dividend. Encompass Health Corp. pays out 13% of its earnings as a dividend. Encompass Health Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but U.S. Physical Therapy, Inc.'s is not.

U.S. Physical Therapy, Inc. quarterly revenues are $202.7M, which are smaller than Encompass Health Corp. quarterly revenues of $1.5B. U.S. Physical Therapy, Inc.'s net income of $13.1M is lower than Encompass Health Corp.'s net income of $201.9M. Notably, U.S. Physical Therapy, Inc.'s price-to-earnings ratio is 58.82x while Encompass Health Corp.'s PE ratio is 19.66x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for U.S. Physical Therapy, Inc. is 1.62x versus 1.88x for Encompass Health Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Elite Health Systems, Inc. has a net margin of 6.45% compared to U.S. Physical Therapy, Inc.'s net margin of --. U.S. Physical Therapy, Inc.'s return on equity of 8.4% beat Elite Health Systems, Inc.'s return on equity of -72.99%.

U.S. Physical Therapy, Inc. has a consensus price target of $105.33, signalling upside risk potential of 26.53%. On the other hand Elite Health Systems, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that U.S. Physical Therapy, Inc. has higher upside potential than Elite Health Systems, Inc., analysts believe U.S. Physical Therapy, Inc. is more attractive than Elite Health Systems, Inc..

U.S. Physical Therapy, Inc. has a beta of 1.301, which suggesting that the stock is 30.094% more volatile than S&P 500. In comparison Elite Health Systems, Inc. has a beta of 0.495, suggesting its less volatile than the S&P 500 by 50.465%.

U.S. Physical Therapy, Inc. has a quarterly dividend of $0.45 per share corresponding to a yield of 2.16%. Elite Health Systems, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. U.S. Physical Therapy, Inc. pays 126.62% of its earnings as a dividend. Elite Health Systems, Inc. pays out -- of its earnings as a dividend.

U.S. Physical Therapy, Inc. quarterly revenues are $202.7M, which are larger than Elite Health Systems, Inc. quarterly revenues of --. U.S. Physical Therapy, Inc.'s net income of $13.1M is higher than Elite Health Systems, Inc.'s net income of -$1.2M. Notably, U.S. Physical Therapy, Inc.'s price-to-earnings ratio is 58.82x while Elite Health Systems, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for U.S. Physical Therapy, Inc. is 1.62x versus 7.08x for Elite Health Systems, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Pediatrix Medical Group, Inc. has a net margin of 6.45% compared to U.S. Physical Therapy, Inc.'s net margin of 6.82%. U.S. Physical Therapy, Inc.'s return on equity of 8.4% beat Pediatrix Medical Group, Inc.'s return on equity of 19.95%.

U.S. Physical Therapy, Inc. has a consensus price target of $105.33, signalling upside risk potential of 26.53%. On the other hand Pediatrix Medical Group, Inc. has an analysts' consensus of $21.33 which suggests that it could grow by 7.31%. Given that U.S. Physical Therapy, Inc. has higher upside potential than Pediatrix Medical Group, Inc., analysts believe U.S. Physical Therapy, Inc. is more attractive than Pediatrix Medical Group, Inc..

U.S. Physical Therapy, Inc. has a beta of 1.301, which suggesting that the stock is 30.094% more volatile than S&P 500. In comparison Pediatrix Medical Group, Inc. has a beta of 0.786, suggesting its less volatile than the S&P 500 by 21.358%.

U.S. Physical Therapy, Inc. has a quarterly dividend of $0.45 per share corresponding to a yield of 2.16%. Pediatrix Medical Group, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. U.S. Physical Therapy, Inc. pays 126.62% of its earnings as a dividend. Pediatrix Medical Group, Inc. pays out -- of its earnings as a dividend.

U.S. Physical Therapy, Inc. quarterly revenues are $202.7M, which are smaller than Pediatrix Medical Group, Inc. quarterly revenues of $493.8M. U.S. Physical Therapy, Inc.'s net income of $13.1M is lower than Pediatrix Medical Group, Inc.'s net income of $33.7M. Notably, U.S. Physical Therapy, Inc.'s price-to-earnings ratio is 58.82x while Pediatrix Medical Group, Inc.'s PE ratio is 10.26x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for U.S. Physical Therapy, Inc. is 1.62x versus 0.89x for Pediatrix Medical Group, Inc.. Usually stocks with elevated PS ratios are considered overvalued.